Differentieringsantigener som normalt finns i ett litet antal celler i lymfkörtlarna och tonsillerna, men som kan framkallas i en mångfald celler in vitro. Kliniskt gör de nytta som markörer för Ki-1- lymfom, och i vissa fall för lymfomatoid papulos, mycosis fungoides och Hodgkins sjukdom.
A member of the tumor necrosis factor receptor superfamily that may play a role in the regulation of NF-KAPPA B and APOPTOSIS. It is found on activated T-LYMPHOCYTES; B-LYMPHOCYTES; NEUTROPHILS; EOSINOPHILS; MAST CELLS and NK CELLS. Overexpression of the Ki-1 antigen in hematopoietic malignancies make it clinically useful as a biological tumor marker. Signaling of the receptor occurs through its association with TNF RECEPTOR-ASSOCIATED FACTORS.
Antigener, CD30 — CD30-antigener — Ber-H2 antigener
Antigen, Ki-1 — Ki 1 Antigen — CD30 Antigens — Antigens, CD30 — Ber-H2 Antigen — Antigen, Ber-H2 — Ber H2 Antigen — TNFRSF8 Receptor — Receptor, TNFRSF8 — Antigens, Ki-1 — Antigens, Ki 1 — Ki-1 Antigens — Ki 1 Antigens — Tumor Necrosis Factor Receptor Superfamily, Member 8 — CD30 Antigen — Antigen, CD30 — Ber-H2 Antigens — Antigens, Ber-H2 — Ber H2 Antigens